Research Topic · Peer-Reviewed

CNS Melanoma

CNS melanoma refers to melanoma that develops in the central nervous system. Melanoma is a type of cancer that arises from pigment-producing cells in the skin. It typically starts with a mole, but can quickly spread to other organs, including the brain. Once it spreads to the brain or spinal cord, it is called CNS m…

📚 0 peer-reviewed articles cited 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

CNS melanoma refers to melanoma that develops in the central nervous system. Melanoma is a type of cancer that arises from pigment-producing cells in the skin. It typically starts with a mole, but can quickly spread to other organs, including the brain. Once it spreads to the brain or spinal cord, it is called CNS melanoma. CNS melanoma is a rare form of melanoma, but it can be devastating. It can cause headaches, seizures, and other neurological symptoms. Treatment for CNS melanoma is challenging, and it often involves a combination of surgery, radiation therapy, and chemotherapy. However, the prognosis for individuals with CNS melanoma is generally poor, with a five-year survival rate of less than 10%. Hematology and Oncology Research have made significant progress in understanding the causes of melanoma and developing advanced treatments. Scientists continue to investigate the genetic and environmental factors that increase the risk of developing melanoma. They are also exploring new therapies that target specific genetic mutations in the cancer cells. 

Research published in this journal

No peer-reviewed research on this exact topic has been published in Hematology and Oncology Research yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.